# Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty

> **NCT07097493** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 90 (estimated)

## Conditions studied

- Knee Arthroplasty, Total

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Bupivacaine, Clonidine, Epinephrine, Buprenorphine and Dexamethasone (BPV-CEBD) Combination

## Key facts

- **NCT ID:** NCT07097493
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07097493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07097493, "Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07097493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*